Methylation patterns in marginal zone lymphoma

Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):24-31. doi: 10.1016/j.beha.2016.09.003. Epub 2016 Nov 5.

Abstract

Promoter DNA methylation is a major regulator of gene expression and transcription. The identification of methylation changes is important for understanding disease pathogenesis, for identifying prognostic markers and can drive novel therapeutic approaches. In this review we summarize the current knowledge regarding DNA methylation in MALT lymphoma, splenic marginal zone lymphoma, nodal marginal zone lymphoma. Despite important differences in the study design for different publications and the existence of a sole large and genome-wide methylation study for splenic marginal zone lymphoma, it is clear that DNA methylation plays an important role in marginal zone lymphomas, in which it contributes to the inactivation of tumor suppressors but also to the expression of genes sustaining tumor cell survival and proliferation. Existing preclinical data provide the rationale to target the methylation machinery in these disorders.

Keywords: CIMP; Decitabine; Lymphoma; MALT; Marginal zone; Methylation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation / genetics*
  • DNA Methylation*
  • DNA, Neoplasm* / genetics
  • DNA, Neoplasm* / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Genome-Wide Association Study
  • Humans
  • Lymphoma, B-Cell, Marginal Zone* / genetics
  • Lymphoma, B-Cell, Marginal Zone* / metabolism
  • Splenic Neoplasms* / genetics
  • Splenic Neoplasms* / metabolism

Substances

  • DNA, Neoplasm